Balance Sheet
Accounts PayablesAssetsCapital LeasesCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityLong-Term Deferred TaxNon-Current AssetsOperating LeasesOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)ReceivablesReceivables - NetRetained EarningsShareholder's EquityShort-term InvestmentsTotal Current LiabilitiesTotal LiabilitiesTotal Non-Current LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Vanda Pharmaceuticals (VNDA) Other Non-Current Assets: 2010-2014

Historic Other Non-Current Assets for Vanda Pharmaceuticals (VNDA) over the last 5 years, with Dec 2014 value amounting to $813,000.

  • Vanda Pharmaceuticals' Other Non-Current Assets rose 3.57% to $813,000 in Q3 2015 from the same period last year, while for Sep 2015 it was $813,000, marking a year-over-year increase of 3.57%. This contributed to the annual value of $813,000 for FY2014, which is 62.60% up from last year.
  • Per Vanda Pharmaceuticals' latest filing, its Other Non-Current Assets stood at $813,000 for FY2014, which was up 62.60% from $500,000 recorded in FY2013.
  • In the past 5 years, Vanda Pharmaceuticals' Other Non-Current Assets ranged from a high of $813,000 in FY2014 and a low of $430,000 during FY2010.
  • In the last 3 years, Vanda Pharmaceuticals' Other Non-Current Assets had a median value of $600,000 in 2012 and averaged $637,667.
  • Per our database at Business Quant, Vanda Pharmaceuticals' Other Non-Current Assets declined by 16.67% in 2013 and then skyrocketed by 62.60% in 2014.
  • Yearly analysis of 5 years shows Vanda Pharmaceuticals' Other Non-Current Assets stood at $430,000 in 2010, then spiked by 39.53% to $600,000 in 2011, then remained steady at $600,000 in 2012, then decreased by 16.67% to $500,000 in 2013, then soared by 62.60% to $813,000 in 2014.